StockData
Jaguar Health, Inc. logo

Jaguar Health, Inc. (JAGX) stock

JAGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.38−0.01 (-2.59%)

Close on Nov 17, 2026Market cap $1.96MP/E –Yield –

Jaguar Health enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Jaguar Health's enterprise value was $158.28B on Jan 31, 2024, against $1,905.96T a year earlier. Over the last 5 years it ranged from $158.28B to $7,441.06T, with a median of $1,354.53T.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2024Jan 31, 2024$158.28B-31.1%
2023Dec 29, 2023$229.79B-100.0%
2022Jan 31, 2022$1,905.96T-21.7%
2021Dec 31, 2021$2,435.13T+811.7%
2020Jan 31, 2020$267.10T-4.1%
2019Dec 31, 2019$278.58T-54.6%
2018Jan 31, 2018$613.00T-9.3%
2017Dec 29, 2017$675.75T-54.9%
2016Dec 30, 2016$1,499.67T+30.9%
2015Dec 31, 2015$1,145.72T–

More Jaguar Health figures

See a number that looks wrong?